Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our triple bottom line focuses on people, the planet, and purpose. Together we are ready to go the extra mile to empower communities while transforming countless lives and industries along the way.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
You have these already downloaded
We have sent you a copy of the report to your email again.
The World Drug Safety Congress (WDSC) Americas 2022, one of the largest congregations of pharmacovigilance (PV) professionals worldwide, brought together 600+ industry stakeholders in pharma to discuss the key challenges faced in pharmacovigilance (PV) and device safety.
TCS was a proud ‘Diamond Sponsor’ for this reputed event and participated with a vision to bridge the gaps enunciated by pharma organizations through a mix of technology, domain and contextual knowledge.
Attendees were able to engage with our core PV leadership team, learnt more about our deep PV transformation expertise and experience our purpose-built solution, TCS ADD™ Safety – An AI Platform for Pharmacovigilance. TCS was a part of multiple speaking sessions wherein speakers from global top 10 pharma joined us and shared insights in the areas of ‘AI and Machine Learning in PV’ and ‘Next Generation Tech & Data – New emerging tech in PV’. We thoroughly enjoyed some really interesting discussions and sharing proof-of-concept stories.
Connect with us to discover how we empower pharma organizations to take the next big leap with AI powered PV.
When AI meets PV
4th Oct | 12PM ET – 12:40PM ET
The Life Sciences industry is at an inflection point with charting out its future journey and envisioning a new approach to PV. With the ever-increasing volume of reported adverse events, there is an immediate need to enable and accelerate digital transformation of the Safety Surveillance processes and experience the benefits of Next-Gen PV. Dr. Alejandra Guerchicoff moderated a dynamic panel of experts with rich real-life experiences in implementation of AI driven PV Platforms while discussing its benefits and challenges.
Industry Leader
TCS ADD™ Safety, TCS
Know More About Dr. Alejandra GuerchicoffExecutive Director
Head of Pharmacovigilance Operations, Amgen
Know More About Michael MurphySenior Vice President Patient Safety
Chief Safety Officer, AstraZeneca
Know More About Mariette Boerstoel StreeflandResearch VP
Life Sciences R&D Strategy & Technology, IDC
Know More About Dr. Nimita LimayeDirector
Life Sciences, TCS
Know More About Dr. Aparna PatkarAI Driven Safety Case Processing – Learnings and Experiences
5th Oct | 11:20AM ET – 11:40AM ET
The past decade has seen unprecedented technology revolution in PV. With a spurt in innovations, advanced scientific discoveries, personalized medicines and global portfolios, the pharma industry must rely on digital technologies to handle the innate complexities.
Technology providers responded by conceptualizing and developing disruptive AI-ML platforms, introduce them into the market and gradually replace the traditional point automation PV tools. In this dynamic and interactive presentation, Naru presented the next-gen solutions for PV and drove the audience into key technical discussions with real experiences of adopting and implementing AI driven PV platforms.
Chief Architect and Head of Clinical & Safety Platforms
TCS ADD™, Tata Consultancy Services
Know More About Narayanan R. (Naru)TCS at NRF 2025: Experience AI Transformation in Action
TCS Corporate Challenge for Standard Chartered Singapore Marathon 2024
TCS BaNCS at CorpActions 2024, London
TCS at OpenText World 2024